PROPICONAZOLE - αποτελεσματα

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

dimax rapid (diclomex rapid) filmuhúðuð tafla 50 mg

alvogen ehf. - diclofenacum kalíum - filmuhúðuð tafla - 50 mg

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

rozlytrek

roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - Æxlishemjandi lyf - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

aprepitant stada hart hylki 125 mg/80 mg

stada arzneimittel ag - aprepitantum inn - hart hylki - 125 mg/80 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin medical valley forðatafla 150 mg

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 150 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin medical valley forðatafla 300 mg

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 300 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin medical valley forðatafla 75 mg

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 75 mg